FDA approves CryoLife's heart patch

08/12/2009 | Forbes

The FDA granted approval to CryoLife for its CryoPatch SG, a human cardiac patch designed to repair or reconstruct the heart's right ventricular outflow tract, a surgery often done for pediatric patients with congenital heart defects. The company plans to start shipping the product late in the third quarter.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN